Wang Song, Li A-Jian, Jiang Hui-Hong, Lin Yin, Ding Hai-Bo
Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China.
World J Gastrointest Surg. 2025 Jul 27;17(7):107525. doi: 10.4240/wjgs.v17.i7.107525.
Rectal cancer ranks as the third most prevalent malignancy globally, with an estimated 1.9 million incident cases reported in 2020. The management of low rectal cancer presents significant therapeutic challenges due to its anatomical complexity, and substantially impacts patients' quality of life. While abdominoperineal resection (Miles procedure) ensures oncological radicality, the morbidity associated with permanent colostomy has driven innovations in sphincter-preserving surgical techniques. This review synthesizes current evidence on sphincter-preserving surgical approaches for low rectal cancer. The implementation of total mesorectal excision (TME) principles and enhanced understanding of circumferential resection margin have facilitated the evolution of diverse sphincter-preserving surgical modalities. These include local excision, low anterior resection (Dixon procedure), intersphincteric resection, pull-through procedures, transanal TME, and conventional sphincter-preserving operation. Minimally invasive approaches, particularly laparoscopic and robotic platforms, alongside natural orifice transluminal endoscopic surgery, have demonstrated improved surgical precision and enhanced postoperative recovery outcomes. Novel functional perineal reconstruction techniques offer promising alternatives for patients requiring posterior pelvic exenteration. Nevertheless, the high incidence of low anterior resection syndrome (LARS) and its chronic sequelae remain clinically notable. Evidence indicates that long-course neoadjuvant radiotherapy and TME constitute significant risk factors for LARS development. Contemporary sphincter-preserving surgery for low rectal cancer is advancing toward minimally invasive, personalized, and precision-based approaches. The increasing incidence of early-onset rectal cancer necessitates individualized treatment strategies that balance oncological efficacy with functional preservation. Future directions should focus on standardizing surgical indications, optimizing postoperative rehabilitation protocols, and enhancing treatment outcomes through multidisciplinary integration and technological innovation.
直肠癌是全球第三大常见恶性肿瘤,2020年估计有190万例新发病例。低位直肠癌的治疗因其解剖结构复杂而面临重大挑战,并对患者的生活质量产生重大影响。虽然腹会阴联合切除术(Miles手术)可确保肿瘤根治性,但永久性结肠造口术相关的发病率推动了保肛手术技术的创新。本综述综合了低位直肠癌保肛手术方法的现有证据。全直肠系膜切除术(TME)原则的实施以及对环周切缘的深入理解促进了多种保肛手术方式的发展。这些手术方式包括局部切除术、低位前切除术(Dixon手术)、括约肌间切除术、拖出术、经肛全直肠系膜切除术以及传统的保肛手术。微创方法,尤其是腹腔镜和机器人平台,以及经自然腔道内镜手术,已显示出更高的手术精度和更好的术后恢复效果。新型功能性会阴重建技术为需要后盆腔脏器清扫术的患者提供了有前景的替代方案。然而,低位前切除综合征(LARS)的高发病率及其慢性后遗症在临床上仍然值得关注。证据表明,长程新辅助放疗和TME是LARS发生的重要危险因素。当代低位直肠癌保肛手术正朝着微创、个性化和精准化的方向发展。早发性直肠癌发病率的上升需要个性化的治疗策略,以平衡肿瘤治疗效果和功能保留。未来的方向应集中在规范手术适应症、优化术后康复方案,以及通过多学科整合和技术创新提高治疗效果。